Drug Industry and Allied Groups Want Rollback of 340B

by Admin | February 13, 2013 2:42 pm

February 13, 2013—A coalition representing drug manufacturers, pharmacy benefit managers, private practice oncologists, and independent pharmacies issued a report[1] yesterday on hospital participation in the 340B drug discount program, arguing that hospitals have strayed from what the groups maintain is 340B’s purpose of helping the uninsured poor “gain better access to prescription medicines.”

Hospitals disputed that finding, saying in a statement[2] that the program meets Congress’ intent of enabling safety-net providers to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” 

---

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[3].    Already registered? Click here to login[4]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Source URL: https://340binformed.org/2013/02/drug-industry-and-allied-groups-want-rollback-of-340b/

---